These molecules are expressed in the tumor stroma and lymphocytes, respectively, and their secretion is regulated by increased expression of TGF-β1 derived from CAFs, underscoring the role of these cells in modulating T cell immunity within the TME (23). The gene discussed is TGFB1; the disease is neoplasm.